Guidance

Antimicrobial intravenous-to-oral switch: criteria for prompt switch

National antimicrobial intravenous-to-oral switch (IVOS) criteria for prompt switch​ have been developed for adult and paediatric patients, categorised into 5 sections.

From:
UK Health Security Agency
Published
1 November 2022
Last updated
424 AprilJune 2024 — See all updates

Documents

National antimicrobial intravenous-to-oral switch (IVOS) criteria for prompt switch for adults

HTML

Antimicrobial IVOS decision aid for adults

PDF, 317 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Antimicrobial IVOS decision aid for adults: text alternative

HTML

National criteria for prompt intravenous-to-oral switch (IVOS) of antimicrobials in children and young people (including newborns)

Ref: GOV-16483

HTML

Antimicrobial intravenous-to-oral switch (IVOS) decision aid for paediatrics

Ref: GOV-16872

PDF, 76.3 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

In 2022, the IVOS criteria for adults were developed through collation of criteria from a sample of 45 acute hospital IVOS policies, completion of a rapid systematic literature review to validate selection of criteria, and a 4-step Delphi consensus-gathering process involving 279 multidisciplinary participants from all UK nations to agree evidence-based, UK-wide IVOS criteria for hospitalised adult patients.

In 2024, paediatric IVOS criteria were also developed. The 29 criteria were co-produced through a UK-wide consensus process involving 170 multidisciplinary participants.

These projects were led by the UK Health Security Agency (UKHSA)’s Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use and Sepsis Division, in collaboration with NHS England AMR Programme and UKHSA’s Behavioural Science and Insights Unit. 

Published 1 November 2022
Last updated 424 AprilJune 2024 + show all updates

  1. Added decision guide for paediatrics.

  2. Added paediatric IVOS prompt early switch criteria. Changed attachment titles to specify for adult patients.

  3. Added IVOS decision aid.

  4. First published.